Endoscopy 2011; 43(4): 282-290
DOI: 10.1055/s-0030-1256309
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Radiofrequency ablation for the endoscopic eradication of esophageal squamous high grade intraepithelial neoplasia and mucosal squamous cell carcinoma

F.  G.  I.  van Vilsteren1 , L.  Alvarez Herrero1 , 2 , R.  E.  Pouw1 , F.  J.  W.  ten Kate3 , M.  Visser3 , C.  A.  Seldenrijk5 , M.  I.  van Berge Henegouwen4 , B.  L.  Weusten1 , 2 , J.  J.  Bergman1
  • 1Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
  • 2Gastroenterology and Hepatology, St Antonius hospital, Nieuwegein, The Netherlands
  • 3Pathology, Academic Medical Center, Amsterdam, The Netherlands
  • 4Surgery, Academic Medical Center, Amsterdam, The Netherlands
  • 5Pathology, St Antonius hospital, Nieuwegein, The Netherlands
Weitere Informationen

Publikationsverlauf

submitted 14 November 2010

accepted after revision 31 January 2010

Publikationsdatum:
31. März 2011 (online)

Background and study aims: Radiofrequency ablation (RFA) with or without prior endoscopic resection safely and effectively removes early neoplasia in Barrett's esophagus. We speculated that this approach might also be suited for early squamous neoplasia of the esophagus. The aim of the study was to assess our initial experiences with RFA for high grade intraepithelial neoplasia (HGIN) and esophageal squamous cell cancer (ESCC) limited to the mucosa.

Patients and methods: This was a prospective case series study in two tertiary centers. Patients with at least one unstained lesion (USL) of the esophagus using Lugol's chromoendoscopy and squamous HGIN/ESCC upon biopsy were included. In the case of nonflat USLs, endoscopic resection was performed for staging and to render the mucosa flat. After endoscopic resection and subsequent circumferential RFA, chromoendoscopy was repeated every 3 months with focal RFA of residual USLs. Follow-up chromoendoscopy was repeated at 6 months and annually thereafter. The main outcome measure was complete histological response for any squamous intraepithelial neoplasia or ESCC.

Results: A total of 13 patients (10 HGIN, three ESCC) were included. Following endoscopic resection in nine patients, the median extent of USLs was 4 cm and 50 % of circumference. All 13 patients achieved a complete response after a median of 2 RFA sessions (IQR 1 – 3 sessions). RFA-related complications included two mucosal lacerations (at the endoscopic resection scar) and one intramural hematoma, none requiring therapy. Endoscopic resection-/RFA-related complications were three stenoses. Dilation resulted in perforation in one patient (managed with a covered stent). There were no recurrences (median follow-up 17 months [IQR 11 – 22 months]).

Conclusions: This study suggests that RFA with or without prior endoscopic resection for esophageal squamous HGIN and mucosal ESCC is feasible and effective.

References

  • 1 Holmes R S, Vaughan T L. Epidemiology and pathogenesis of esophageal cancer.  Semin Radiat Oncol. 2007;  17 2-9
  • 2 Parkin D M, Bray F, Ferlay J et al. Global cancer statistics, 2002.  CA Cancer J Clin. 2005;  55 74-108
  • 3 Araki K, Ohno S, Egashira A et al. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis.  Cancer. 2002;  94 570-575
  • 4 Eguchi T, Nakanishi Y, Shimoda T et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases.  Mod Pathol. 2006;  19 475-480
  • 5 Katada C, Muto M, Momma K et al. Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae – a multicenter retrospective cohort study.  Endoscopy. 2007;  39 779-783
  • 6 Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan.  Surgery. 1998;  123 432-439
  • 7 Birkmeyer J D, Siewers A E, Finlayson E V et al. Hospital volume and surgical mortality in the United States.  N Engl J Med. 2002;  346 1128-1137
  • 8 Peters F P, Kara M A, Curvers W L et al. Multiband mucosectomy for endoscopic resection of Barrett's esophagus: feasibility study with matched historical controls.  Eur J Gastroenterol Hepatol. 2007;  19 311-315
  • 9 Peters F P, Brakenhoff K P, Curvers W L et al. Endoscopic cap resection for treatment of early Barrett's neoplasia is safe: a prospective analysis of acute and early complications in 216 procedures.  Dis Esophagus. 2007;  20 510-515
  • 10 Westerterp M, Koppert L B, Buskens C J et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction.  Virchows Arch. 2005;  446 497-504
  • 11 Ciocirlan M, Lapalus M G, Hervieu V et al. Endoscopic mucosal resection for squamous premalignant and early malignant lesions of the esophagus.  Endoscopy. 2007;  39 24-29
  • 12 Giovannini M, Bernardini D, Moutardier V et al. Endoscopic mucosal resection (EMR): results and prognostic factors in 21 patients.  Endoscopy. 1999;  31 698-701
  • 13 Pech O, Gossner L, May A et al. Endoscopic resection of superficial esophageal squamous-cell carcinomas: Western experience.  Am J Gastroenterol. 2004;  99 1226-1232
  • 14 Pech O, May A, Gossner L et al. Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia.  Endoscopy. 2007;  39 30-35
  • 15 Seewald S, Ang T L, Omar S et al. Endoscopic mucosal resection of early esophageal squamous cell cancer using the Duette mucosectomy kit.  Endoscopy. 2006;  38 1029-1031
  • 16 Ishihara R, Iishi H, Takeuchi Y et al. Local recurrence of large squamous-cell carcinoma of the esophagus after endoscopic resection.  Gastrointest Endosc. 2008;  67 799-804
  • 17 Ono S, Fujishiro M, Niimi K et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms.  Gastrointest Endosc. 2009;  70 860-866
  • 18 Gondrie J J, Pouw R E, Sondermeijer C M et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients.  Endoscopy. 2008;  40 359-369
  • 19 Gondrie J J, Pouw R E, Sondermeijer C M et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system.  Endoscopy. 2008;  40 370-379
  • 20 Pouw R E, Wirths K, Eisendrath P et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia.  Clin Gastroenterol Hepatol. 2009;  8 23-29
  • 21 Egan J V, Baron T H, Adler D G et al. Esophageal dilation.  Gastrointestinal Endoscopy. 2006;  63 755-760
  • 22 Langdon D F. The rule of three in esophageal dilation.  Gastrointestinal Endoscopy. 1997;  45 111
  • 23 Dunkin B J, Martinez J, Bejarano P A et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device.  Surg Endosc. 2006;  20 125-130
  • 24 Ganz R A, Utley D S, Stern R A et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus.  Gastrointest Endosc. 2004;  60 1002-1010
  • 25 Pouw R E, Gondrie J J, Curvers W L et al. Successful balloon-based radiofrequency ablation of a widespread early squamous cell carcinoma and high-grade dysplasia of the esophagus: a case report.  Gastrointest Endosc. 2008;  68 537-541
  • 26 The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002.  Gastrointest Endosc. 2003;  58 (Suppl. 6) S3-S43
  • 27 Pouw R E, Bergman J J. Endoscopic resection of early oesophageal and gastric neoplasia.  Best Pract Res Clin Gastroenterol. 2008;  22 929-943
  • 28 Kato H, Haga S, Endo S et al. Lifting of lesions during endoscopic mucosal resection (EMR) of early colorectal cancer: implications for the assessment of resectability.  Endoscopy. 2001;  33 568-573
  • 29 Van Vilsteren F G, Bergman J J. Endoscopic therapy using radiofrequency ablation for esophageal dysplasia and carcinoma in Barrett's esophagus.  Gastrointest Endosc Clin N Am. 2010;  20 55-74 , vi
  • 30 Riphaus A, Wehrmann T, Weber B et al. S3 Guideline: Sedation for gastrointestinal endoscopy 2008.  Endoscopy. 2009;  41 787-815
  • 31 Hamilton S R, Aaltonen L A. World Health Organization Classification of Tumours. Pathology and genetics of tumours of the digestive system.. Lyon: IARC Press; 2000
  • 32 Pouw R E, Seewald S, Gondrie J J. et al . Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.  Gut. 2010;  59 1169-1177
  • 33 Deprez P H, Yeung R C, Aouattah T et al. Prospective randomized comparison between EMR and ESD for endoscopic removal of superficial esophageal cancer.  Gastrointestinal Endoscopy. 2008;  67 AB187
  • 34 Fleischer D E, Overholt B F, Sharma V K et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up.  Gastrointest Endosc. 2008;  68 867-876
  • 35 Shaheen N J, Sharma P, Overholt B F et al. Radiofrequency ablation in Barrett's esophagus with dysplasia.  N Engl J Med. 2009;  360 2277-2288
  • 36 Smith C D, Bejarano P A, Melvin W S et al. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system.  Surg Endosc. 2007;  21 560-569
  • 37 van Vilsteren F GI, Pouw R E, Seewald S et al. A multi-center randomized trial comparing stepwise radical endoscopic resection versus radiofrequency ablation for Barrett esophagus containing high-grade dysplasia and/or early cancer.  Gastrointestinal Endoscopy. 2009;  69 AB133-AB134

J. BergmanMD, PhD 

Department of Gastroenterology and Hepatology
Academic Medical Center

Meibergdreef 9
1105 AZ Amsterdam
The Netherlands

Fax: +31-20-6917033

eMail: j.j.bergman@amc.uva.nl

    >